Shop Talk : Oncology Times
An abstract is unavailable.
Related Articles
Descending facilitation from rostral ventromedial medulla… : PAIN
e heterozygous (MORCre) or wild-type (MORWT) mice received AAV8-hSyn-DIO-hM4D(Gi)-mCherry in the RVM. After partial sciatic nerve ligation (PSNL), we evaluated pain behaviors and descending control…
Dr Naqash on Combining Abequolixron Plus Docetaxel in Recurrent NSCLC
Abdul Rafeh Naqash, MD, discusses the potential role for abequolixron plus docetaxel in recurrent advanced non–small cell lung cancer.
9 States Poised To End Coverage for Millions if Trump Cuts Medicaid Funding – KFF Health News
About 3.7 million people are at immediate risk of losing health coverage should the federal government cut funding for Medicaid expansions, as some allies of…
Avapritinib Yields Improvements in Bone Density in Advanced Systemic Mastocytosis
Treatment with avapritinib was associated with dynamic changes in bone density based on lumbar T-scores among patients with systemic mastocytosis.
The U.S. Food and Drug Administration (FDA) Approves Acalabrutinib (Calquence) for Mantle Cell Lymphoma
Latest News The U.S. Food and Drug Administration (FDA) Approves Acalabrutinib (CALQUENCE) for Mantle Cell Lymphoma January 16, 2025 – On January 16,
Upregulated spinal histone deacetylases induce nociceptive… : PAIN Reports
ibitory neurotransmitter that can inhibit NP. The present study aimed to examine the role of spinal HDAC and its isoforms in neuropathy. Methods: Male Wistar…
Aspiring Professional Musician Finds Success in Moffitt’s Arts in Medicine Program
Corbin Smith is one of five artists-in-residence at the cancer center
Biomarker Panels for Discriminating Risk of CKD Progression … : Journal of the American Society of Nephrology
re each independently associated with CKD progression in children. In this study, we used bootstrapped survival trees to identify a combination of biomarkers to predict…
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients…
